Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 8;2017(1):699-707.
doi: 10.1182/asheducation-2017.1.699.

Pharmacologic agents to prevent and treat relapse after allogeneic hematopoietic cell transplantation

Robert J Soiffer  1   2   3 , Yi-Bin Chen  3   4
Affiliations
Review

Pharmacologic agents to prevent and treat relapse after allogeneic hematopoietic cell transplantation

Robert J Soiffer et al. Hematology Am Soc Hematol Educ Program. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: R.J.S. has consulted for Sandoz, Juno, and Kiadis. Y.-B.C has consulted for Takeda, Magenta, Incyte, and Jazz.

Figures

Figure 1.
Figure 1.
Different approaches to post-transplantation therapies after allogeneic HCT including treatment vs preemptive vs maintenance. (Adapted with permission from Defilipp and Chen.)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Wingard JR, Majhail NS, Brazauskas R, et al. . Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2011;29(16):2230-2239. - PMC - PubMed
    1. Thanarajasingam G, Kim HT, Cutler C, et al. . Outcome and prognostic factors for patients who relapse after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19(12):1713-1718. doi:10.1016/j.bbmt.2013.09.011. - PMC - PubMed
    1. Kekre N, Kim HT, Thanarajasingam G, et al. . Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantation. Haematologica. 2015;100(9):1222-1227. - PMC - PubMed
    1. Armand P, Kim HT, Zhang MJ, et al. . Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biol Blood Marrow Transplant. 2012;18(2):280-288. doi:10.1016/j.bbmt.2011.07.024. - PMC - PubMed
    1. Armand P, Kim HT, Logan BR, et al. . Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. Blood. 2014;123(23):3664-3671. - PMC - PubMed

Substances